Healthcare provider profile · identity verified

Mitchell L Seitz, M.D.

Internal Medicine · TRACY, CA · NPI 1518943190

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	159
Levothyroxine Sodium	Levothyroxine Sodium	402	93
Amlodipine Besylate	Amlodipine Besylate	309	91
Losartan Potassium	Losartan Potassium	237	59
Alendronate Sodium	Alendronate Sodium	213	50
Lisinopril	Lisinopril	205	54
Tamsulosin Hcl	Tamsulosin Hcl	194	49
Rosuvastatin Calcium	Rosuvastatin Calcium	180	45
Ozempic	Semaglutide	163	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	34
Omeprazole	Omeprazole	147	37
Metformin Hcl Er	Metformin Hcl	137	35
Sertraline Hcl	Sertraline Hcl	130	35
Finasteride	Finasteride	121	28
Zolpidem Tartrate	Zolpidem Tartrate	119	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	35
Pantoprazole Sodium	Pantoprazole Sodium	115	25
Jardiance	Empagliflozin	108	24
Albuterol Sulfate Hfa	Albuterol Sulfate	101	51
Metformin Hcl	Metformin Hcl	100	23
Furosemide	Furosemide	97	25
Ezetimibe	Ezetimibe	91	27
Gabapentin	Gabapentin	90	30
Hydrochlorothiazide	Hydrochlorothiazide	90	18
Potassium Chloride	Potassium Chloride	90	24
Simvastatin	Simvastatin	80	19
Carvedilol	Carvedilol	75	21
Metoprolol Succinate	Metoprolol Succinate	71	19
Clopidogrel	Clopidogrel Bisulfate	67	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	20
Azithromycin	Azithromycin	59	47
Trulicity	Dulaglutide	57	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	16
Pregabalin	Pregabalin	54	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	53	12
Montelukast Sodium	Montelukast Sodium	53	11
Alprazolam	Alprazolam	51	15
Triamcinolone Acetonide	Triamcinolone Acetonide	49	23
Tramadol Hcl	Tramadol Hcl	48	17
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Allopurinol	Allopurinol	37	13
Lorazepam	Lorazepam	37	suppressed
Eliquis	Apixaban	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Atenolol	Atenolol	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Clonazepam	Clonazepam	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	14
Famotidine	Famotidine	29	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	29	12
Trazodone Hcl	Trazodone Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	12
Repatha Sureclick	Evolocumab	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	13
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Naproxen	Naproxen	25	19
Prolia	Denosumab	25	15
Teriparatide	Teriparatide	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Colchicine	Colchicine	22	suppressed
Levofloxacin	Levofloxacin	22	18
Cephalexin	Cephalexin	21	15
Ibuprofen	Ibuprofen	21	12
Memantine Hcl	Memantine Hcl	21	suppressed
Glipizide	Glipizide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Felodipine Er	Felodipine	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Diazepam	Diazepam	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Meloxicam	Meloxicam	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Modafinil	Modafinil	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Prednisone	Prednisone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Temazepam	Temazepam	11	suppressed
Testosterone	Testosterone	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error